戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  features included increased muscle tone and muscle cramps.
2 r features included a history of myalgia and muscle cramps.
3 er characterized by exercise intolerance and muscle cramps.
4 ively, shed light on contributing factors to muscle cramps.
5 t adverse events were joint pain (15 [38%]), muscle cramp (15 [38%]), and fatigue (12 [31%]) in the 2
6 nd included alopecia (29%), dysgeusia (29%), muscle cramps (29%), and anorexia (14%).
7 usea or vomiting (25%), fatigue (27.3%), and muscle cramps (4.5%).
8 old items (71%), throat discomfort (63%), or muscle cramps (42%).
9 ere localized pain, swelling, itchiness, and muscle cramping after accidental envenomation.
10                                              Muscle cramps, alopecia, weight loss, fatigue, and dysge
11  and bloating and in dizziness, headache and muscle cramps, although the decrease in systemic symptom
12                                              Muscle cramps and hypophosphatemia were more common in t
13 m the 702 patients screened, 195 (27.8%) had muscle cramps, and 91 (13.0%) met the inclusion criteria
14 without elevated CK levels, muscle weakness, muscle cramps, and persistent myalgia and CK elevations
15 ction, pickle brine and taurine for reducing muscle cramps, and tadalafil for improving sexual dysfun
16 with cirrhosis experience symptoms including muscle cramps (approximately 64% prevalence), pruritus (
17                                              Muscle cramps are among the common debilitating complica
18 presented in middle life with incapacitating muscle cramps associated with calf hypertrophy and only
19 atological (pruritus and dry skin), painful (muscle cramps, chest pain and abdominal pain) or involve
20 ients with confirmed liver cirrhosis who had muscle cramps >= 4 times per month without other seconda
21 rade 1 or 2 adverse events of loss of taste, muscle cramps, hair loss, and weight loss.
22 e and mobility impairment, sensory symptoms, muscle cramps, impaired upper limb function, respiratory
23 ing the frequency, duration, and severity of muscle cramps in patients with liver cirrhosis.
24 on during dialysis, refractory symptoms (eg, muscle cramps, itching), and malfunction of dialysis acc
25 ulting in gain of function, manifesting with muscle cramping, myalgias, and rod formation in F5.
26 ncluded weight loss of 20% or more (n=6) and muscle cramps (n=2).
27 of danazol--elevated liver-enzyme levels and muscle cramps--of grade 2 or less occurred in 41% and 33
28                       Many symptoms, such as muscle cramps, poor-quality sleep, pruritus, and sexual
29              He also experienced progressive muscle cramps, profound sweating, bowel disturbances (di
30 is characterized by sensory paresthesias and muscle cramps that are notably exacerbated by cooling.
31 month without other secondary etiologies for muscle cramps were evaluated for inclusion.
32    Other acute effects included diarrhea and muscle cramping, while with repeated dosing, anorexia an